| scholarly article | Q13442814 |
| P2093 | author name string | Judson A Brewer | |
| Sandip Bhattacharyya | |||
| Louis J Muglia | |||
| Diane E Brown | |||
| Sherri K Vogt | |||
| P2860 | cites work | Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene | Q22299417 |
| Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. | Q24537701 | ||
| The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 | Q28185796 | ||
| A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells | Q28237789 | ||
| Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway | Q28270455 | ||
| Antiinflammatory action of glucocorticoids--new mechanisms for old drugs | Q28278037 | ||
| Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1 | Q28366337 | ||
| Innate immunity: the virtues of a nonclonal system of recognition | Q29614428 | ||
| Negative regulation of toll-like receptor-mediated immune responses | Q29619019 | ||
| Single-dose pharmacokinetics and pharmacodynamics of RWJ 67657, a specific p38 mitogen-activated protein kinase inhibitor: a first-in-human study. | Q51536797 | ||
| Inhibition of p38 mitogen-activated protein kinase: dose-dependent suppression of leukocyte and endothelial response after endotoxin challenge in humans. | Q51721285 | ||
| T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation | Q73886490 | ||
| Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models | Q74138408 | ||
| MAPK p38 antagonism as a novel method of inhibiting lymphoid immune suppression in polymicrobial sepsis | Q74154176 | ||
| p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes | Q77732872 | ||
| PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines | Q29620217 | ||
| Points of control in inflammation | Q29620319 | ||
| Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase | Q30439838 | ||
| Subnuclear trafficking and gene targeting by steroid receptors | Q33204998 | ||
| Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis | Q33581637 | ||
| Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines | Q33648231 | ||
| Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways | Q33715487 | ||
| Rapid actions of steroid receptors in cellular signaling pathways. | Q34135517 | ||
| Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta | Q34331980 | ||
| Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses | Q34479244 | ||
| Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic | Q35163045 | ||
| Recognition of microbial infection by Toll-like receptors | Q35192575 | ||
| The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression | Q35200339 | ||
| Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis | Q35573332 | ||
| Nuclear receptor signaling in macrophages. | Q35617588 | ||
| Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell | Q35666145 | ||
| Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation | Q35912822 | ||
| Inflammation suppressor genes: please switch out all the lights | Q36073369 | ||
| MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock | Q36227887 | ||
| The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin | Q36326164 | ||
| How Toll-like receptors signal: what we know and what we don't know | Q36339101 | ||
| The many paths to p38 mitogen-activated protein kinase activation in the immune system | Q36518938 | ||
| Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. | Q37372701 | ||
| Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor | Q38293939 | ||
| LXR-dependent gene expression is important for macrophage survival and the innate immune response | Q38335500 | ||
| Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia | Q38919861 | ||
| Blockade of p38 map kinase inhibits complement-induced acute lung injury in a murine model | Q39359497 | ||
| Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent | Q40373664 | ||
| The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. | Q40482210 | ||
| The function of mitogen-activated protein kinase phosphatase-1 in peptidoglycan-stimulated macrophages | Q40504212 | ||
| Janus kinase 2 is involved in lipopolysaccharide-induced activation of macrophages | Q40657235 | ||
| Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages | Q40688402 | ||
| The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. | Q40919510 | ||
| Prostaglandin endoperoxide H synthases-1 and -2. | Q41090404 | ||
| Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. | Q41812359 | ||
| Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor | Q41839655 | ||
| Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. | Q42135532 | ||
| Elevated levels of cyclooxygenase-2 in antigen-stimulated mast cells is associated with minimal activation of p38 mitogen-activated protein kinase | Q42507664 | ||
| Conditional gene targeting in macrophages and granulocytes using LysMcre mice. | Q44554898 | ||
| Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids | Q45099909 | ||
| Receptor-independent activation of GABAergic neurotransmission and receptor-dependent nontranscriptional activation of phosphatidylinositol 3-kinase/protein kinase Akt pathway in short-term cardiovascular actions of dexamethasone at the nucleus trac | Q45137080 | ||
| Homodimerization of the glucocorticoid receptor is not essential for response element binding: activation of the phenylethanolamine N-methyltransferase gene by dimerization-defective mutants | Q46771342 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macrophage | Q184204 |
| toll-like receptor | Q408004 | ||
| inflammation | Q101991 | ||
| P304 | page(s) | 4313-4319 | |
| P577 | publication date | 2007-01-25 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase | |
| P478 | volume | 109 |
| Q37655884 | 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action |
| Q38682652 | Airway Epithelial Cells Are Crucial Targets of Glucocorticoids in a Mouse Model of Allergic Asthma. |
| Q40096656 | Anti-Inflammatory Chromatinscape Suggests Alternative Mechanisms of Glucocorticoid Receptor Action |
| Q99609481 | Arthritis and the role of endogenous glucocorticoids |
| Q92239413 | Cdk5 Deletion Enhances the Anti-inflammatory Potential of GC-Mediated GR Activation During Inflammation |
| Q38084054 | Changing glucocorticoid action: 11β-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation. |
| Q90468752 | Chronic Gestational Inflammation: Transfer of Maternal Adaptation over Two Generations of Progeny |
| Q61821145 | Circadian variation in pulmonary inflammatory responses is independent of rhythmic glucocorticoid signaling in airway epithelial cells |
| Q99564973 | Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy |
| Q37039999 | Corticosteroid use in neurocysticercosis |
| Q33636430 | Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases |
| Q42811539 | Cyclic AMP inhibits JNK activation by CREB-mediated induction of c-FLIP(L) and MKP-1, thereby antagonizing UV-induced apoptosis |
| Q47297664 | Dexamethasone inhibits activation of monocytes/macrophages in a milieu rich in 27-oxygenated cholesterol |
| Q34289063 | Dual-specificity MAP kinase phosphatases (MKPs): shaping the outcome of MAP kinase signalling |
| Q92305405 | Effect of pregnancy hormone mixtures on cytokine production and surface marker expression in naïve and LPS-activated THP-1 differentiated monocytes/macrophages |
| Q60307179 | Effects of Glucocorticoid-Induced Transcript 1 Gene Deficiency on Glucocorticoid Activation in Asthmatic Mice |
| Q37622977 | Effects of dexamethasone and meloxicam on Borrelia burgdorferi-induced inflammation in glial and neuronal cells of the central nervous system |
| Q57038956 | Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells |
| Q28073947 | Endothelial Response to Glucocorticoids in Inflammatory Diseases |
| Q92800308 | Fighting the Fire: Mechanisms of Inflammatory Gene Regulation by the Glucocorticoid Receptor |
| Q30898776 | Gene network and pathway analysis of bovine mammary tissue challenged with Streptococcus uberis reveals induction of cell proliferation and inhibition of PPARgamma signaling as potential mechanism for the negative relationships between immune [...] |
| Q50065331 | Glucocorticoid Signaling in Health and Disease: Insights From Tissue-Specific GR Knockout Mice |
| Q42183307 | Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation |
| Q89573972 | Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis |
| Q42155077 | Glucocorticoid regulation of mouse and human dual specificity phosphatase 1 (DUSP1) genes: unusual cis-acting elements and unexpected evolutionary divergence |
| Q36953713 | Glucocorticoid signaling in myeloid cells worsens acute CNS injury and inflammation |
| Q35585748 | Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells |
| Q47144286 | Glucocorticoid-induced phosphorylation by CDK9 modulates the coactivator functions of transcriptional cofactor GRIP1 in macrophages. |
| Q33681241 | Glucocorticoids Suppress Antimicrobial Autophagy and Nitric Oxide Production and Facilitate Mycobacterial Survival in Macrophages |
| Q37347677 | Glucocorticoids exacerbate lipopolysaccharide-induced signaling in the frontal cortex and hippocampus in a dose-dependent manner. |
| Q38983832 | Glucocorticoids improve endothelial function in rheumatoid arthritis: a study in rats with adjuvant-induced arthritis |
| Q98735430 | Glucocorticoids in Sepsis: To Be or Not to Be |
| Q91898018 | Glucocorticoids inhibit macrophage differentiation towards a pro-inflammatory phenotype upon wounding without affecting their migration |
| Q35898425 | Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1. |
| Q34218546 | Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome. |
| Q28590220 | Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation |
| Q37013589 | Glucocorticoids, developmental 'programming' and the risk of affective dysfunction |
| Q28538546 | Haploinsufficiency of Def activates p53-dependent TGFβ signalling and causes scar formation after partial hepatectomy |
| Q91986570 | Host immune responses during Taenia solium Neurocysticercosis infection and treatment |
| Q47124070 | Host resistance to endotoxic shock requires the neuroendocrine regulation of group 1 innate lymphoid cells. |
| Q39133550 | Immune regulation by glucocorticoids. |
| Q92424082 | In vivo liposomal delivery of PPARα/γ dual agonist tesaglitazar in a model of obesity enriches macrophage targeting and limits liver and kidney drug effects |
| Q47107945 | Inhibition of IRAK1 Ubiquitination Determines Glucocorticoid Sensitivity for TLR9-Induced Inflammation in Macrophages. |
| Q41869015 | Inhibition of hydrogen sulfide production by gene silencing attenuates inflammatory activity by downregulation of NF-κB and MAP kinase activity in LPS-activated RAW 264.7 cells. |
| Q38515285 | Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration. |
| Q36506932 | Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection. |
| Q47956445 | Lipopolysaccharide regulates biosynthesis of cystathionine γ-lyase and hydrogen sulfide through Toll-like receptor-4/p38 and Toll-like receptor-4/NF-κB pathways in macrophages |
| Q37583613 | Low molecular weight hyaluronan activates cytosolic phospholipase A2α and eicosanoid production in monocytes and macrophages. |
| Q37186699 | MAP kinase phosphatase-1, a critical negative regulator of the innate immune response |
| Q41543269 | Macrophage 11β-HSD-1 deficiency promotes inflammatory angiogenesis |
| Q41911561 | Mechanisms of dexamethasone-mediated inhibition of Toll-like receptor signaling induced by Neisseria meningitidis and Streptococcus pneumoniae |
| Q38765627 | MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response |
| Q41819611 | Microsomal Prostaglandin E Synthase-1 Expression in Inflammatory Conditions Is Downregulated by Dexamethasone: Seminal Role of the Regulatory Phosphatase MKP-1. |
| Q34016521 | Mite allergen Der-p2 triggers human B lymphocyte activation and Toll-like receptor-4 induction |
| Q36301783 | Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease |
| Q38151234 | Mitogen-activated protein kinase phosphatase 1 as an inflammatory factor and drug target |
| Q46331188 | Modulation of glucocorticoid receptor expression, inflammation, and cell apoptosis in septic guinea pig lungs using methylprednisolone |
| Q90050688 | More Than Suppression: Glucocorticoid Action on Monocytes and Macrophages |
| Q36645845 | Negative regulatory approaches to the attenuation of Toll-like receptor signaling |
| Q57181221 | Neuroendocrine regulation of innate lymphoid cells |
| Q38951098 | New Insights in Glucocorticoid Receptor Signaling-More Than Just a Ligand-Binding Receptor |
| Q26765156 | New dimension of glucocorticoids in cancer treatment |
| Q99637269 | New insights into the cell- and tissue-specificity of glucocorticoid actions |
| Q39403485 | Nocodazole increases the ERK activity to enhance MKP-1expression which inhibits p38 activation induced by TNF-α. |
| Q42218200 | Non-canonical Glucocorticoid Receptor Transactivation of gilz by Alcohol Suppresses Cell Inflammatory Response |
| Q35274791 | Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanisms |
| Q26830948 | One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids |
| Q37619758 | Opposing effects of prednisolone treatment on T/NKT cell- and hepatotoxin-mediated hepatitis in mice |
| Q24643034 | Pathogen recognition and inflammatory signaling in innate immune defenses |
| Q42369143 | Plasmodium berghei NK65 in Combination with IFN-γ Induces Endothelial Glucocorticoid Resistance via Sustained Activation of p38 and JNK. |
| Q45148973 | Possible involvement of toll-like receptors in the pathogenesis of myasthenia gravis |
| Q40534425 | Presentation of Cryptic Peptides by MHC Class I Is Enhanced by Inflammatory Stimuli. |
| Q36107304 | Progesterone and the Repression of Myometrial Inflammation: The Roles of MKP-1 and the AP-1 System |
| Q37094068 | Protein tyrosine phosphatases: dual-specificity phosphatases in health and disease |
| Q37628186 | Resistance of LPS-activated bone marrow derived macrophages to apoptosis mediated by dexamethasone |
| Q37187064 | Role of dual specificity phosphatases in biological responses to glucocorticoids. |
| Q34703094 | Role of mitogen-activated protein kinase phosphatase-1 in corticosteroid insensitivity of chronic oxidant lung injury |
| Q33567588 | Scavenger receptor BI and high-density lipoprotein regulate thymocyte apoptosis in sepsis |
| Q33357388 | Sequential expression of TLR4 and its effects on the myocardium of rats with myocardial ischemia-reperfusion injury |
| Q34419566 | Social regulation of leukocyte homeostasis: the role of glucocorticoid sensitivity |
| Q35800588 | Suppression of Dendritic Cell-Derived IL-12 by Endogenous Glucocorticoids Is Protective in LPS-Induced Sepsis |
| Q40200983 | Suppression of LPS-induced inflammatory responses by the hydroxyl groups of dexamethasone. |
| Q33722684 | TAK1 targeting by glucocorticoids determines JNK and IkappaB regulation in Toll-like receptor-stimulated macrophages |
| Q37689538 | The HPA - Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain |
| Q37732574 | The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights |
| Q28076811 | The control of inflammation via the phosphorylation and dephosphorylation of tristetraprolin: a tale of two phosphatases |
| Q41271719 | The effects of red ginseng saponin fraction-A (RGSF-A) on phagocytosis and intracellular signaling in Brucella abortus infected RAW 264.7 cells |
| Q36888160 | The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore. |
| Q37568769 | The ginsenoside metabolite compound K, a novel agonist of glucocorticoid receptor, induces tolerance to endotoxin-induced lethal shock |
| Q37338762 | The links between chronic obstructive pulmonary disease and comorbid depressive symptoms: role of IL-2 and IFN-γ. |
| Q38050401 | The multiple facets of glucocorticoid action in rheumatoid arthritis |
| Q38020956 | The neuroendocrine control of the innate immune system in health and brain diseases |
| Q37010312 | The role of MAP kinase phosphatase-1 in the protective mechanism of dexamethasone against endotoxemia |
| Q37634610 | The role of scaffold proteins in JNK signalling |
| Q40176500 | Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling |
| Q28389670 | Titanium dioxide nanoparticles stimulate sea urchin immune cell phagocytic activity involving TLR/p38 MAPK-mediated signalling pathway |
| Q33741912 | Transcriptional regulation of human dual specificity protein phosphatase 1 (DUSP1) gene by glucocorticoids |
| Q55069197 | Transforming growth factor-β-activated kinase 1 resistance limits glucocorticoid responsiveness to Toll-like receptor 4-mediated inflammation. |
Search more.